title: Safety and feasibility of subcutaneous low molecular weight heparin for cerebral venous sinus thrombosis.
abstract: OBJECTIVE
  The effect of low molecular weight heparin (LMWH) in the management of cerebral venous thrombosis (CVT) remains unclear. The present study was performed to determine the safety and feasibility of subcutaneous LMWH, with particular attention to hemorrhagic conversions.
  
  
  METHODS
  LMWH (nadroparin, 7,500 ICU, every 12 hours) was administered subcutaneously for 14 days to 12 patients diagnosed with CVT. Initial clinical manifestations, etiologies and the clinical courses after LMWH treatment were also evaluated. Possible hemorrhagic side effects, including aggravation of the initial hemorrhage and/or newly developed-hemorrhagic conversions were monitored by image analysis.
  
  
  RESULTS
  Headaches and convulsive movements were frequent presenting symptoms for CVT. Clinical improvement was usually observed within 2 to 8 days after LMWH. Symptom stabilization was observed within 4 to 60 days. Neither clinical aggravations, nor newly developed parenchymal lesions were observed during LMWH maintenance. Associated parenchymal lesions were observed in 9 of the 12 patients, 5 of which manifested with hemorrhagic conversion, as detected by image analysis. However, no clinical and radiologic aggravation was noted in these 5 patients.
  
  
  CONCLUSIONS
  Our results suggest that LMWH may be safe and feasible in the management of CVT.
authors.affiliation: Department of Neurology, College of Medicine, Chungnam National University, Daejeon, Korea.
authors.forename: Ji Seon
authors.initials: JS
authors.lastname: Kim
authors.forename: Seong Hae
authors.initials: SH
authors.lastname: Jeong
authors.forename: Dae Hyun
authors.initials: DH
authors.lastname: Kim
authors.forename: Jei
authors.initials: J
authors.lastname: Kim
references.citation: N Engl J Med. 1997 Sep 4;337(10):688-98
references.pmid: 9278467
references.citation: Lancet. 1991 Nov 2;338(8775):1154
references.pmid: 1682581
references.citation: Am Heart J. 2002 Jun;143(6):952-60
references.pmid: 12075248
references.citation: J Thromb Haemost. 2005 Mar;3(3):473-81
references.pmid: 15748236
references.citation: JAMA. 2004 Jul 7;292(1):101-3
references.pmid: 15238598
references.citation: Arch Neurol. 1988 May;45(5):567-72
references.pmid: 3282499
references.citation: Stroke. 1987 May-Jun;18(3):656-60
references.pmid: 3296334
references.citation: JAMA. 2004 Jul 7;292(1):55-64
references.pmid: 15238591
references.citation: Lancet. 1991 Sep 7;338(8767):597-600
references.pmid: 1679154
references.citation: Am J Med. 1996 Mar;100(3):269-77
references.pmid: 8629671
references.citation: J Thromb Haemost. 2003 Sep;1(9):1906-13
references.pmid: 12941030
references.citation: Neurol Clin. 1992 Feb;10(1):87-111
references.pmid: 1557011
references.citation: N Engl J Med. 1991 May 30;324(22):1565-74
references.pmid: 2027360
references.citation: Br J Surg. 1995 Apr;82(4):496-501
references.pmid: 7613894
references.citation: Thromb Haemost. 1989 Dec 29;62(4):1046-9
references.pmid: 2559484
references.citation: Cerebrovasc Dis. 1998 Nov-Dec;8(6):331-7
references.pmid: 9774750
references.citation: J Bone Joint Surg Br. 1991 May;73(3):434-8
references.pmid: 1670445
references.citation: Stroke. 2003 Apr;34(4):1054-5
references.pmid: 12649520
references.citation: CMAJ. 1998 Oct 20;159(8):931-8
references.pmid: 9834718
references.citation: Stroke. 1999 Mar;30(3):484-8
references.pmid: 10066840
references.citation: Thromb Haemost. 1998 Feb;79(2):259-63
references.pmid: 9493572
references.citation: Thromb Haemost. 1994 Aug;72(2):186-90
references.pmid: 7831649
references.citation: Lancet. 1991 Nov 2;338(8775):1153-4
references.pmid: 1682580
references.citation: Arch Intern Med. 1995 Mar 27;155(6):601-7
references.pmid: 7887755
references.citation: Ann Intern Med. 2004 Feb 3;140(3):175-83
references.pmid: 14757615
references.citation: Circulation. 2004 Dec 14;110(24 Suppl 1):IV13-9
references.pmid: 15598642
references.citation: J Neurol Neurosurg Psychiatry. 1995 Jul;59(1):1-3
references.pmid: 7608694